Rocket Lab Shares Surge 8.2% as Cantor Reiterates $122 Target on Record Backlog and Neutron Launch

The Quick Take

• Rocket Lab (RKLB) shares jumped 8.2% after Cantor Fitzgerald reiterated its Overweight rating and $122 price target
• Company holds a record $2.36 billion backlog, providing strong multi-year revenue visibility
• Upcoming Neutron rocket launch and Iridium acquisition are key catalysts in focus for investors

Synthesized from 1 source — full coverage, sentiment breakdown, and forward signals below.

Rocket Lab shares gained 8.2% following Cantor Fitzgerald's reiteration of an Overweight rating and $122 price target for RKLB, with the brokerage's conviction underpinned by the company's record $2.36 billion backlog. The backlog figure represents contracted revenue across launch services, satellite components, and space systems integration — providing multi-year visibility that is unusual for a company at Rocket Lab's revenue stage. Cantor's analysis indicates that the backlog quality, customer mix, and contract term structure support the brokerage's long-term revenue and margin growth thesis.

Two near-term catalysts are in sharp investor focus: the upcoming Neutron rocket launch and the planned Iridium satellite services acquisition. The Neutron rocket — Rocket Lab's medium-lift launch vehicle under development — represents a significant step-up from the existing Electron rocket into higher-value commercial and government payload markets. A successful Neutron launch would position Rocket Lab as a genuine SpaceX Falcon 9 competitor for the medium-lift segment, expanding the addressable market substantially. The Iridium acquisition, if completed, would add operational satellite communication services to Rocket Lab's capabilities, transforming it from a pure launch services provider into a more diversified space infrastructure company.

For investors watching the space economy sector, Rocket Lab's combination of a proven track record (50+ consecutive successful Electron launches), a growing backlog, and high-visibility catalysts in Neutron and Iridium positions it as one of the most investable pure-play space companies outside of SpaceX. The 8.2% surge on broker affirmation reflects the market's sensitivity to institutional endorsement in a sector where investor conviction can shift rapidly on technical milestones. India's space sector, accelerating under ISRO's private sector liberalisation and the launch of IN-SPACe, closely watches Rocket Lab's business model as a template for what private launch companies can achieve.